Wednesday Nov 25 | The Daily Times
C. Ronald Bilowith, 71, of Ocean View, formerly of Clifton, N.J., died Sunday, Nov.
German Pharmaceutical Wholesaler Fiebig Goes Live With IBS Pharma
Sydney, NSW, November 20, 2009 -- Pharmaceutical wholesaler Leopold Fiebig has now fully implemented the IBS Pharma for its industry-specific, highly customized financial accounting processes which, as a result, are now completely integrated with the entire business.
China Biotech Week in Review: CROs Consolidating
In late October, when PPD, Inc. acquired fellow CRO Excel PharmaStudies, we suggested more CRO consolidation might follow.
PPD will take Belgian firm's drugs through Phase II
PPD Inc. said Tuesday that it has signed a deal with Belgian drug-maker Janssen Pharmaceutica N.V. to take two developmental compounds through Phase II trials and possibly to market.
PPD buying BioDuro in China expansion
Drug development contractor Pharmaceutical Product Development Inc. said Wednesday it will buy BioDuro LLC in a move to expand capabilities in China.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.
PPD and Janssen Pharmaceutica Collaborate to Develop Compounds for...
PPD, Inc. today announced it has entered an agreement with Janssen Pharmaceutica N.V. to develop and commercialize two Phase II-ready therapeutic compounds, one to treat diarrhea-predominant irritable bowel syndrome and the other to treat complicated skin and skin structure and respiratory infections.
Ore Pharmaceutical Holdings reports financial results and provides...
Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.
How Do You Say 'Drug Development' in Mandarin?
I've been critical of pharma's claims that developing countries are going to save them from the inevitable patent cliffs.
PPD Declares Fourth Quarter Dividend
PPD, Inc. today announced its board of directors declared a cash dividend for the fourth quarter of 2009 under its annual cash dividend policy.
Takeda sues Teva over insomnia medicine
Takeda Pharmaceutical Co., Asia's biggest drugmaker, sued Teva Pharmaceutical Industries Ltd., alleging infringement of a U.S. patent for the insomnia treatment Rozerem.
PPD Completes Acquisition of Excel PharmaStudies
PPD, Inc. today announced it has completed its acquisition of Excel PharmaStudies, Inc., the market leader and one of the largest contract research organizations in China.
China Biotech Week in Review: Is CRO Consolidation a New Theme?
Is consolidation the new theme in China's fragmented CRO sector? Over the past five to ten years, an almost bewildering array of new CROs has sprung into existence.
Pharmaceutical Product Development plans to spin off its drug development business and capitalize it with $100 million.
PPD Makes Significant Inroad into China Biotech with Single Deal
PPD, Inc. announced it has reached an agreement to acquire Excel PharmaStudies, Inc., a China-based CRO specializing in Phase II-IV clinical trials.
FDA awards PPD $2.7M contract to review drug surveillance system
Get the latest news alerts: Follow LTW at Twitter. Local Tech Wire WILMINGTON, N.C. How effective is the Food and Drug Administration's system for monitoring adverse reactions to products? Pharmaceutical Product Development has won a $2.7 million contract to measure the effectiveness of the post-market surveillance system operated by the FDA's ...
PPD signs agreement to invest $100 million in Celtic Therapeutics Holdings
PPD, Inc. today announced it has signed an agreement to invest $100 million in Celtic Therapeutics Holdings L.P., an investment partnership organized for the purpose of identifying, acquiring and investing in a diversified portfolio of 10 to 15 novel therapeutic product candidates.
PPD Announces Plans to Spin off Compound Partnering Business
PPD, Inc. today announced its board of directors has authorized management to proceed with preparations to spin off its compound partnering : business from its core contract research organization, or CRO, business.
PPD to Acquire Excel PharmaStudies
PPD, Inc. today announced it has entered into an agreement to acquire Excel PharmaStudies, Inc.
PPD Awarded U.S. Food and Drug Administration Contract to Evaluate...
PPD, Inc. today announced it has been awarded a contract by the U.S. Food and Drug Administration to evaluate the agencya s Center for Drug Evaluation and Research post-market spontaneous adverse event surveillance system.